Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Payal Sojitra

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
British Journal of Haematology|November 17, 2024
Somatic co-alteration signatures are prognostic in high-grade TP53-mutated myeloid neoplasmsEmily O Symes, Peng Wang, Payal Sojitra, et al.
Journal of Clinical Pathology|June 26, 2025
Karyotypic clonal fraction predicts adverse outcome in <i>TP53</i>-mutated myeloid neoplasms: an International <i>TP53</i> investigators Network (iTiN) studyMadhavi Pandiri, Anna Stengel, Jingjing Zhang, et al.
Cancer|December 19, 2025
Characterization of chromosome 5 aberrations in TP53 mutated myeloid neoplasms with ≥5% blasts: An International TP53 Investigators Network (iTiN) studyIrfan Yasin, Anna Stengel, Haipeng Shao, et al.
Blood Cancer Journal|June 18, 2024
Real world predictors of response and 24-month survival in high-grade TP53-mutated myeloid neoplasmsAmandeep Kaur, Alexandra E Rojek, Emily Symes, et al.
American Journal of Hematology|July 2, 2025
Prognostic Implication of Karyotypic Evaluation in Patients With Richter Transformation in the Modern EraCecelia R Miller, Ying Huang, John N Allan, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
British Journal of Haematology|November 17, 2024
Somatic co-alteration signatures are prognostic in high-grade TP53-mutated myeloid neoplasmsEmily O Symes, Peng Wang, Payal Sojitra, et al.
Journal of Clinical Pathology|June 26, 2025
Karyotypic clonal fraction predicts adverse outcome in <i>TP53</i>-mutated myeloid neoplasms: an International <i>TP53</i> investigators Network (iTiN) studyMadhavi Pandiri, Anna Stengel, Jingjing Zhang, et al.
Cancer|December 19, 2025
Characterization of chromosome 5 aberrations in TP53 mutated myeloid neoplasms with ≥5% blasts: An International TP53 Investigators Network (iTiN) studyIrfan Yasin, Anna Stengel, Haipeng Shao, et al.
Blood Cancer Journal|June 18, 2024
Real world predictors of response and 24-month survival in high-grade TP53-mutated myeloid neoplasmsAmandeep Kaur, Alexandra E Rojek, Emily Symes, et al.
American Journal of Hematology|July 2, 2025
Prognostic Implication of Karyotypic Evaluation in Patients With Richter Transformation in the Modern EraCecelia R Miller, Ying Huang, John N Allan, et al.
Pageof 2